Disorders with complex clinical outcomes that often involve multiple systems. Early identification and standardized clinical care are critical to improving prognosis. Diagnosis of the disease requires a combination of clinical outcomes, imaging checks, laboratory tests and pathological evaluations.
The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of the treatment of PML-associated white blood cells require individualized development, typically including multidimensional management of drug therapy, rehabilitation, regular follow-up, and so on. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many of the diseases of the nervous system that have previously been difficult to treat have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes according to changes in the disease. Multidisciplinary collaboration (MDT) is especially important for the integrated management of white blood cells around the brain surrounding PML. The platform serves a team of nationally and internationally authoritative experts in the field of neural systems related to the International Medical Service System of China, providing the following services to patients: 1.
Remote pre-diagnosis: Pre-examination of medical records, clear diagnostic directions and medical advice by a team of experts; 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.